All “breakthrough therapy” designation requests for products regulated by the Center for Drug Evaluation and Research are evaluated by the center’s Medical Policy Council.
The council provides a senior-level forum for establishing medical policy in the center and ensuring consistent application across review divisions Also see "CDER Medical Policy Council Balances “Breakthrough” Requests...